What the research supports, what remains uncertain, and what to ask
Written by the Regen Provider Guide editorial team and checked against published research. Educational information only—not medical advice.
Peptide therapy—including BPC-157, TB-500, and a growing list of other compounds—has become a prominent subject in wellness, sports medicine, and regenerative care. It is also frequently misunderstood. This guide explains what peptides are, the limits of current evidence, and practical questions for consumers.
What are peptides?
Peptides are short chains of amino acids, the same building blocks that make up proteins. The human body naturally produces many peptides. Synthetic peptides are also used in approved medicines and are promoted in some clinics for healing, recovery, body composition, or other purposes.
Products marketed for tissue repair may include BPC-157, TB-500 or TB-4, CJC-1295 with ipamorelin, tesamorelin, GHK-Cu, and others. These products do not all have the same evidence, approval status, quality controls, or risks.
What does the science say?
Much of the excitement around several popular recovery peptides comes from animal or laboratory studies. For example, BPC-157 has shown potentially interesting effects in preclinical research. However, high-quality human evidence for many of the healing claims remains limited or absent.
Promising animal results do not establish that a substance is safe or effective in people. This is not a reason to dismiss future research; it is a reason to be cautious about guaranteed results or confident claims that run ahead of human clinical evidence.
Regulatory status and sourcing
Many peptides promoted for healing or recovery—including BPC-157, TB-500, and MOTS-C—are not FDA-approved for those uses. Eligibility for compounding depends on current federal policy and the specific substance, and legal status can change.
Products obtained from unregulated sources may have uncertain identity, purity, and dosing. Ask a licensed clinician and dispensing pharmacy to explain the current regulatory status and source of any product being considered.
Questions to ask
- Which specific peptide are you recommending, and for what diagnosis or goal?
- What human evidence supports it for my situation—not only animal studies?
- Is it FDA-approved for this use, eligible for compounding, or otherwise lawful to prescribe and dispense?
- Where is the product sourced, compounded, and independently tested?
- What are the known risks, possible interactions, and important unknowns?
- How will benefits and adverse effects be monitored?
- Could its use violate professional or athletic drug-testing rules?
The bottom line
Peptides are an active area of research, but the marketplace often moves faster than the evidence and regulation. Consumers should approach them with a qualified clinician, realistic expectations, and careful attention to product sourcing and legal status. Because policy and evidence can change, confirm current information with the FDA and a licensed clinician before making a decision.
Sources and further reading
- American Orthopaedic Society for Sports Medicine—The Boom of Peptides in Sports Medicine
- Narrative review—BPC-157: Regeneration or Risk?
- U.S. FDA—Human Drug Compounding
